Expression, purification and monoclonal antibodies preparation of recombinant equine mature interleukin-18.

The researchers expressed and purified a recombinant version of the horse protein interleukin-18 (IL-18). They then exposed mice to this protein to generate multiple monoclonal antibodies, which can potentially neutralize the activity of horse IL-18.

Expression and Purification of Recombinant Equine Mature Interleukin-18

• This research centres around a protein called IL-18, a cytokine that plays a crucial role in regulating immune responses.
• The researchers engineered a version of this protein derived from horses, called recombinant equine mature interleukin-18 (rEMIL-18), and expressed it in E. coli, a common host organism for protein production.
• Following expression, they purified the rEMIL-18 protein using nickel affinity gel column chromatography, a technique that relies on the affinity of certain proteins for nickel to separate them from other components.
• They confirmed that the simulated equine IL-18 was biologically active, based on its ability to work together with another protein called recombinant human IL-12 to induce the gene expression of interferon gamma (IFN-gamma) in horse white blood cells. Both IL-18 and IL-12 are known to stimulate the production of IFN-gamma, a critical molecule in the immune response.

Production and Characterization of Monoclonal Antibodies

• Monoclonal antibodies (mAbs) are antibodies that are made by identical immune cells which are all clones of a unique parent cell. They are widely used in medical and biological research due to their specificity for a single site (epitope) on the molecule they are designed to target.
• The purified rEMIL-18 was injected into BALB/c mice, a strain of mice widely used in research. The body’s immune system responded by producing antibodies against rEMIL-18.
• The researchers were able to isolate nine different monoclonal antibodies (mAbs) that specifically recognized equine IL-18. This recognition was characterised by their reactivity with two peptides with different amino acid sequences that comprise EMIL-18.
• One of these isolated mAbs was found to be capable of neutralizing the activity of horse IL-18 in a test that measures induction of IFN-gamma. This suggests potential applications in managing the immune response, as IL-18 plays a vital role in inflammation and autoimmune disorders.